ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT SHULTZ M.D.

Endocrinology, Diabetes Metabolism

21,600

$1.36M

424
372 are 65+

20%
patients receiving schedule two controlled substances

Avg: 0%

26%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 51%

$63
Average prescription price

Avg: $143

SACHIN BAHL M.D.

Endocrinology, Diabetes Metabolism

16,949

$1.84M

1170
907 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 51%

$109
Average prescription price

Avg: $143

GERALDO SAAVEDRA M.D.

Endocrinology, Diabetes Metabolism

14,367

$1.86M

535
274 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 51%

$129
Average prescription price

Avg: $143

MICHAEL ADLER M.D.

Endocrinology, Diabetes Metabolism

13,625

$1.53M

1136
865 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 51%

$112
Average prescription price

Avg: $143

VIJAY BAHL MD

Endocrinology, Diabetes Metabolism

12,293

$1.61M

1045
857 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 51%

$131
Average prescription price

Avg: $143

SILVANA YOVANOF M.D.

Endocrinology, Diabetes Metabolism

9,731

$592K

354
253 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

22%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 51%

$61
Average prescription price

Avg: $143

CAMILLE BUONOCORE M.D.

Endocrinology, Diabetes Metabolism

9,544

$1.35M

846
683 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 51%

$141
Average prescription price

Avg: $143

SWARNA VARMA M.D.

Endocrinology, Diabetes Metabolism

9,338

$1.61M

403
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 51%

$172
Average prescription price

Avg: $143

ANNE LAROCHELLE M.D.

Endocrinology, Diabetes Metabolism

9,159

$1.48M

1057
755 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 51%

$162
Average prescription price

Avg: $143

RECAREDO BERBANO MD

Endocrinology, Diabetes Metabolism

8,947

$1.12M

635
443 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 51%

$125
Average prescription price

Avg: $143

STEPHAN KOWALYK M.D.

Endocrinology, Diabetes Metabolism

8,490

$1.36M

975
742 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 51%

$160
Average prescription price

Avg: $143

JANE MAYRIN MD

Endocrinology, Diabetes Metabolism

8,080

$907K

461
368 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 51%

$112
Average prescription price

Avg: $143

GREGORY BOROWSKI M.D.

Endocrinology, Diabetes Metabolism

7,036

$742K

411
303 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 51%

$106
Average prescription price

Avg: $143

ELIHU GOREN MD PHD

Endocrinology, Diabetes Metabolism

6,935

$1.05M

770
667 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 51%

$151
Average prescription price

Avg: $143

WAYNE EVRON M.D.

Endocrinology, Diabetes Metabolism

6,815

$1.08M

763
553 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 51%

$158
Average prescription price

Avg: $143

STEPHEN MITROSKY D.O.

Endocrinology, Diabetes Metabolism

6,723

$646K

388
269 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 51%

$96
Average prescription price

Avg: $143

MATTHEW KANE MD

Endocrinology, Diabetes Metabolism

6,415

$930K

706
585 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 51%

$145
Average prescription price

Avg: $143

JAY SPRINGER MD

Endocrinology, Diabetes Metabolism

6,283

$723K

525
439 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 51%

$115
Average prescription price

Avg: $143

FERROL LEE M.D.

Endocrinology, Diabetes Metabolism

6,234

$1.07M

545
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 51%

$171
Average prescription price

Avg: $143

STEVEN NAGELBERG MD

Endocrinology, Diabetes Metabolism

6,134

$843K

510
427 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 51%

$137
Average prescription price

Avg: $143

MAL HOMAN MD

Endocrinology, Diabetes Metabolism

6,113

$1.15M

581
418 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 51%

$189
Average prescription price

Avg: $143

MICHAEL HUMPHREY D.O.

Endocrinology, Diabetes Metabolism

5,966

$840K

546
418 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 51%

$141
Average prescription price

Avg: $143

MARGRIT SHOEMAKER MD

Endocrinology, Diabetes Metabolism

5,485

$637K

510
373 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 51%

$116
Average prescription price

Avg: $143

MUSHTAQ SYED MD

Endocrinology, Diabetes Metabolism

5,420

$911K

408
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 51%

$168
Average prescription price

Avg: $143

MANI BASHYAM M.D.

Endocrinology, Diabetes Metabolism

5,389

$880K

631
438 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 51%

$163
Average prescription price

Avg: $143

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank